Mineralys Therapeutics (MLYS) Announces Proposed $250M Share Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. PCG
2. NVDA
3. AVGO
4. ALNY
5. CNS
6. ATTO
7. BRVE
8. EIX
9. EC
10. APO

Go back to Mineralys Therapeutics (MLYS) Announces Proposed $250M Share Offering

Goldman Sachs Reiterates Buy Rating on Mineralys Therapeutics, Inc. (MLYS)

March 10, 2025 4:03 PM EDT

Goldman Sachs analyst Richard Law reiterated a Buy rating and $24.00 price target on Mineralys Therapeutics, Inc. (NASDAQ: MLYS)

The analyst comments "Earlier this morning, MLYS presented positive topline data for lorundrostat's pivotal Ph. 3 Launch-HTN and Ph. 2 Advance-HTN studies in 3/4L uncontrolled and resistant hypertension (uHTN/rHTN). Launch-HTN met its primary endpoint, with placebo-adjusted SBP reductions of 9.1 mmHg (16.9 mmHg absolute)... More